Immune system activation and inflammation accompanies immune dysfunction in trauma and sepsis patients. Tryptophan degradation via the kynurenine pathway by the cytokine-inducible enzyme indoleamine 2,3-dioxygenase (IDO) could contribute to the deficient responsiveness of immunocompetent cells. Activated IDO in patients after trauma and with sepsis is indicated by an increased kynurenine to tryptophan ratio (kyn/trp), which was found to be associated with poor outcome of patients. In this study, tryptophan and kynurenine concentrations in 18 patients post trauma or with sepsis during 12-14 days of follow up (up to 84 specimens were available) were compared to concentrations of neopterin and cytokines tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) and the in vitro response of lipopolysaccharide-stimulated monocytes. Compared to healthy controls, average kyn/trp and kynurenine, TNF-α, IL-6 and neopterin concentrations were increased in patients, and tryptophan concentrations were decreased. During follow-up, only kyn/trp, kynurenine and neopterin concentrations (all p <0.001) were increasing, whereas the changes of tryptophan, TNF-α and IL-6 concentrations were not significant. Non-survivors presented not only with higher kyn/trp and with higher kynurenine and neopterin concentrations than survivors, but also TNF-α and IL-6 concentrations were higher. Kyn/trp correlated with neopterin (r s = 0.590; p <0.001) and also with TNF-α (r s = 0.374; p <0.01) and IL-6 concentrations (r s = 0.262; p <0.05) and inversely with the in vitro response of stimulated monocytes. Data imply that increased tryptophan degradation in patients post trauma is due to IDO activation. Increased IDO activity most likely represents a result of host defence response in patients, and data support a possible role of IDO to diminish immunoresponsiveness in such patients.
Introduction
In patients with multiple trauma or with sepsis, significant activation of various immune system compartments is obvious, and it is accompanied by diminished functional immune response and immune paralysis (1) . The inflammatory response in patients with multiple trauma and sepsis may play a crucial role for the fate of the patient. Enzyme indoleamine 2,3-dioxygenase (IDO) is strongly inducible by pro-inflammatory stimuli and preferentially by cytokine interferon-γ (IFN-γ) and converts tryptophan to kynurenine (2, 3) . Activated IDO diminishes the availability of the essential amino acid Tryptophan and is considered as an immune defence mechanism, which suppresses the growth of intracellular bacteria, viruses and parasites like toxoplasma and of malignant tumor cells (3) (4) (5) . But also T-cell proliferation can be inhibited by IDO activity (6) , and thus, immune response may suffer when tryptophan is diminished and toxic catabolites accumulate. In patients after multiple trauma, tryptophan deficiency was found to correlate with the decline of lymphocyte counts (7) . Moreover, a higher rate of tryptophan degradation is significantly associated with non-survival in such patients (8) .
In patients with trauma and sepsis increased neopterin concentrations were described to predict unfavourable outcome (9, 10) . The pro-inflammatory Th1-type cytokine IFN-γ induces IDO and neopterin production in human monocyte-derived macrophages and dendritic cells (DC) in parallel (11, 12) . Accordingly, in several groups of patients, e.g. suffering from infections, autoimmune syndromes and cancer, enhanced tryptophan degradation concurs with increased neopterin formation (13) (14) (15) (16) . Also in patients with multiple trauma increased neopterin production are paralleled by activation of IDO (7, 8) . This finding could represent a key to understand the negative contribution which immune activation and production of pro-inflammatory cytokines might have in patients. In trauma patients, plasma concentrations of neopterin as well as plasma concentrations of pro-inflammatory cytokines such as TNF-α and interleukin-6 (IL-6) are able to predict outcome (1, 17, 18) . Tumor necrosis factor-α (TNF-α) accelerates both, neopterin production and tryptophan degradation, in a synergistic manner (19) . In this study, the relationship between concentrations of tryptophan and kynurenine and kyn/trp and concentrations of neopterin, TNF-α and IL-6 were analyzed in patients with trauma and results was compared to the outcome of patients.
Materials and Methods
Eighteen patients (14 males, 4 females; aged mean± S.D.: 45 ± 19 years, range: 20 -77 years, 15 post-trauma with sepsis and 3 with sepsis alone; Apache score: 18.9 ± 6.75 range: 8-34; ISS: 39 ± 13.1, range: 18-57) who were admitted either to the Intensive Care Unit (ICU) of the Medical University of Vienna or the ICU of the Lorenz Boehler Trauma Center Vienna, were included in this study (Table 1) . Specimens were collected during 12 -14 days of follow up every third day. For further statistical analyses, specimens were divided into five groups: one specimen collected between days 1-2 of each patient was referred to group I, day 3-5 = group II, day 6-8 = III, days 9-12 = group IV, and days 13-14 = group V. In total every patient contributed 3-5 specimens to the total number of 84 sera analyzed, which corresponds to 6 missing specimens over the whole period.
The observed values of all study parameters had no influence whatsoever on the course of the therapy. The study was performed according to the Helsinki declaration. The protocol was approved by the local ethics committee, and written consent was granted by the next of kin.
Concentrations of tryptophan and kynurenine were determined by HPLC (20, 21) . Neopterin was measured by ELISA (BRAHMS, Hennigsdorf/Berlin, Germany) according to the manufacturer's instructions with a detection limit of 2 nM. Serum levels of TNFand IL-6 were measured with Immulite semi-automated chemoluminescent immuno-assay analyzer (DPC, Los Angeles, CA; detection limits were 1.7 pg/mL for TNF-α and 2 pg/mL for IL-6). Results of these measurements were compared to earlier data on the ex vivo stimulation of monocytes with lipopolysaccharide (LPS) with a commercially available test kit (Ex Vivo Stimulation Kit, Milenia Biotec GmbH, Bad Nauheim, Germany) (22) . Fifty microliters of heparinized whole blood was added to a pyrogen-free stimulation solution containing 500 pg/mL of LPS in culture medium (RPMI 1640, pyrogen-free). After 4h of incubation at 37°C, tubes were centrifuged, and supernatants were stored at -70°C for further measurement of TNF-α on the Immulite semi-automated chemiluminescent immunoassay analyzer (DPC, Los Angeles, CA).
Demographic parameters were compared using the 
Results
Kyn/trp and concentrations of kynurenine, neopterin, TNF-α and IL-6 were increased in patients compared to the normal range in healthy controls, concentrations of tryptophan were decreased (Table 2 ).
However, TNF-α was detectable in only 29/68 (42.6%) specimens. During follow-up, increasing kyn/trp, kynurenine and neopterin concentrations were observed ( Fig. 1) . Kynurenine, kyn/trp and neopterin increased from day 1 to 4 (all p <0.01), kyn/trp and neopterin further increased already from day 4 to 7 (both p <0.01), and troughout the whole follow-up period, kyn/trp and neopterin concentrations remained higher than baseline (all p <0.01). The decline of tryptophan during follow-up did not reach the level of statistical significance. Concentrations of TNF-α and IL-6 showed a kind of a U-shaped development, changes were significant for IL-6 only ( Fig. 1) . At baseline, none of the serum parameters correlated with Apache scores of patients.
Patients who died during follow-up presented with significantly higher kyn/trp, neopterin and kynurenine concentrations during several days; (Fig. 2) . Tryptophan concentrations were lower in non-survivors compared to survivors but did not differ significantly, on day 13, the decline of tryptophan became nearly significant (U = 1.820, p = 0.068). Also TNF-α (p <0.05 on days 1 and 7; p <0.01 on days 10 and 13) and IL-6 (days 1 and 13; p <0.05) concentrations were higher in patients who died compared to survivors.
In the whole data set, there existed an inverse correlation between tryptophan and neopterin concentrations, (r s = -0.238, p = 0.015), whereas kynurenine concentrations (r s = 0.472) and kyn/trp (r s = 0.544; both p <0.0001; Fig. 3 ) correlated positively with neopterin, kyn/trp correlated also with TNF-α (r s = 0.435, p <0.001) and IL-6 concentrations (r s = 0.349, p = 0.001; Fig. 3 ). TNF-α correlated with neopterin (r s = 0.630, p <0.001) but IL-6 did not correlate with neopterin (r s = 0.094, not significant) concentrations, IL-6 also correlated with TNF-α (r s = 0.348, p = 0.001) concentrations (details not shown).
Ex vivo TNF-α production by LPS-stimulated monocytes was significantly decreased in the patients as compared to healthy controls, non-survivors having even lower levels than survivors (22) . Comparing tryptophan degradation and neopterin production rates with the ex vivo TNF-α production by LPS-stimulated monocytes, significant inverse correlations were found between TNF-α production and kyn/trp (r s = -0.470, p <0.001), kynurenine (r s = -0.436, p <0.001) and neopterin (r s = -0.236, p <0.01) as well as with TNF-α (r s = -0.365, p <0.001) and IL-6 (r s = -0.496, p <0.001), whereas the correlation between TNF-α production and tryptophan was slightly positive (r s = 0.204, p <0.05; details not shown).
Discussion
This study shows that tryptophan metabolism is altered in patients suffering from trauma and/or sepsis compared to healthy controls. Compared to healthy controls, kynurenine concentrations and kyn/trp were elevated in patients, whereas tryptophan concentrations were decreased. During follow-up, a higher rate of kynurenine accumulation and of tryptophan degradation as indicated by higher kyn/trp and was predictive for mortality. These results confirm and extend earlier observations on enhanced degradation of tryptophan by IDO in patients after major trauma (7, 8) . Increase of neopterin formation was observed in parallel to the increase of kynurenine concentrations and of kyn/trp which indicates that Th1-type immune activation, may be the cause for accelerated tryptophan degradation due to enhanced IDO activity. Low tryptophan concentrations are unlikely to be related to a reduced dietary intake of this essential amino acid, because in this case also a decrease of kynurenine and no change of kyn/trp would be expected. Increased IDO activity may indeed account for lowered tryptophan concentrations, and seems likely to be induced by pro-inflammatory stimuli, of which IFN-γ together with TNF-α are considered to be the strongest inducer of IDO in macrophages and DC. Immunocompetent cells appear to respond against non-self structures, and cells produce cytokines including IFN-γ aimed at halting growth of pathogens.
Activation of IDO as one out of several important antimicrobial mechanisms triggered by IFN-γ however not only affects microbes, it potentially may also counteract growth and development of T-cells (6). TNF-α was shown earlier to enhance tryptophan degradation and neopterin production in monocyte-derived macrophages in a synergistic way to IFN-γ (19) . In our patients we found some significant correlation between kyn/trp and TNF-α concentrations, but this correlation was weaker than the one between kyn/trp and neopterin. The accelerated tryptophan degradation and the increased production of neopterin and of proinflammatory cytokines were found to be associated with a reduced responsiveness of monocytes upon ex vivo stimulation with LPS. Probably the chronic stimulation and cytokine production during disease progression renders these cells refractory to further stimulation.
TNF-α was not detectable in more than half of the patients, and measurement of circulating IFN-γ concentrations in serum/plasma of patients is usually even less detectable than TNF-α. That is why we refrained from analyzing IFN-γ concentrations in our patients. These cytokines rapidly stick to their specific receptors on target cells or their shed soluble forms, so their low concentrations in the blood are limiting the diagnostic application. TNF-α and IL-6 concentrations were higher in non-survivors compared to survivors already at baseline confirming earlier results of others (17, 18) , and detectable TNF-α concentrations predicted mortality throughout the later post-traumatic course, whereas IL-6 concentrations were less predictive. In addition, a rather strong relationship existed between TNF-α and neopterin concentrations. Overall, the changes of kyn/trp and of kynurenine, neopterin, TNF-α and IL-6 concentrations post trauma showed similar courses in the non-survivors, and they seemed to reflect the pro-inflammatory cascades quite well, which were related to overwhelming production TNF-α and probably also of IFN-γ. Thus, pro-inflammatory cytokines seemed to trigger those critical events leading to death (24) , and tryptophan degradation via IDO could indeed represent one of the most important players. This is a surprising result, because at first glance one might expect that a higher degree of immune response should be in favour of increased patients' survival, when, e.g. clearance of pathogens might be enhanced by the antimicrobial mechanisms, but obviously the opposite is the case. A kind of equilibrium might develop between the activation degree of immunocompetent cells, their suppressive effect on microbes and also on themselves. In some patients the bactericidal effect of IDO will be able to stop the infectious process, in others immunocompetent cells are suffering from IDO activity more than the microbes, and then depletion of T-cells and immunosuppression is a consequence of the host's immune response against invading pathogens. Certainly this study is too preliminary to give a final answer to this question.
A similar relationship between enhanced tryptophan degradation and immune activation was found earlier in several other chronic diseases, like HIV-1 infection or malignancy (13) (14) (15) . Moreover, in patients with HIV-1 infection and with cancer, enhanced tryptophan degradation and increased neopterin production were found to strongly predict shortened survival (25) (26) (27) . to immunodeficiency and may explain why immune activation markers are strong predictors of outcome (28, 29) . From in vitro studies it was concluded that not only the decline of tryptophan concentrations but also the increase formation of toxic tryptophan catabolites could be involved in the development of T-cell unresponsiveness (30) . Interestingly in our study, only the increase of kynurenine concentrations but not the decline of tryptophan was significantly associated with the outcome of the patients. Supplementation of tryptophan via standard parenteral nutrition was initiated early in all our patients. It may have counteracted to some degree the loss of tryptophan despite further accelerating degradation of the amino acid and further increase of kynurenine concentrations. Still, data may favour a role of tryptophan catabolites rather than tryptophan lowering in the immune deviations which might be of relevance for the fatal outcome of some of our patients. Tryptophan deficiency resulting from its accelerated catabolism could also be involved in the increased risk for developing anemia, cachexia and neuropsychiatric abnormalities like depressive mood in patients after trauma or with sepsis (14, 31, 32) . Still, the relevance of this assumption needs to be clarified in further extended studies.
In conclusion, accelerated tryptophan degradation is a prognostic factor for shortened survival in patients post trauma. The same was true for higher concentrations of neopterin and TNF-α, which confirms and extends earlier data. Tryptophan degradation may represent one important aspect in the development of the post traumatic failure of the immune system to respond appropriately. More extended and follow-up studies examining the impact of tryptophan degradation and its relationship with cellular immune activation in patients suffering from trauma may provide interesting new data, which should be helpful to define new therapeutic intervention strategies. Larger clinical studies are necessary to find out more about the potential prognostic expressiveness of tryptophan metabolism in patients suffering from trauma.
